We are live on
!
Find out more
ROTUOC
Regents of the University of California Portfolio holdings
AUM
$4.36B
1-Year Est. Return
33.89%
This Fund
S&P 500
This Quarter
Est. Return
+6.95%
1 Year Est. Return
+33.89%
3 Year Est. Return
+86.09%
5 Year Est. Return
+63.96%
10 Year Est. Return
+870.04%
AUM
$784M
AUM Growth
+$16.5M
(+2.1%)
Cap. Flow
-$29.5M
Cap. Flow
% of AUM
-3.76%
Top 10 Holdings %
Top 10 Hldgs %
96.19%
Holding
38
New
6
Increased
1
Reduced
4
Closed
4
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Opendoor
OPEN
|
+$21.1M |
| 2 |
Alibaba
BABA
|
+$18.9M |
| 3 |
Upstart Holdings
UPST
|
+$18.3M |
| 4 |
Nurix Therapeutics
NRIX
|
+$16.8M |
| 5 |
Snowflake
SNOW
|
+$2.79M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Blue Owl Capital
OBDC
|
+$58.6M |
| 2 |
Allogene Therapeutics
ALLO
|
+$23.9M |
| 3 |
DoorDash
DASH
|
+$18.6M |
| 4 |
RAPT
RAPT Therapeutics
RAPT
|
+$5.08M |
| 5 |
Palantir
PLTR
|
+$2.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 73.99% |
| 2 | Healthcare | 10.56% |
| 3 | Consumer Discretionary | 9.08% |
| 4 | Real Estate | 2.69% |
| 5 | Consumer Staples | 1.48% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Blue Owl Capital
OBDC
$5.75B
| $551M | 70.32% |
38,609,751
-4,081,092
| -10% | -$58.6M |
|
|
2
Alibaba
BABA
$300B
| $69.4M | 8.86% |
306,031
+85,005
| +38% | +$18.9M |
|
|
RAPT
3
DELISTED
RAPT Therapeutics
RAPT
| $24.9M | 3.18% |
97,824
-27,176
| -22% | -$5.08M |
|
|
4
Opendoor
OPEN
$3.39B
| $21.1M | 2.69% |
+1,229,182
| New | +$21.1M |
|
|
CNST
5
DELISTED
Constellation Pharmaceuticals, Inc.
CNST
| $21M | 2.68% |
621,541
| – | – |
|
|
6
Upstart Holdings
UPST
$2.83B
| $18.6M | 2.38% |
+149,031
| New | +$18.3M |
|
7
Intellia Therapeutics
NTLA
$1.69B
| $18M | 2.3% |
111,440
| – | – |
|
|
8
Nurix Therapeutics
NRIX
$2.76B
| $15.2M | 1.93% |
+571,212
| New | +$16.8M |
|
9
Estee Lauder
EL
$31.7B
| $10.6M | 1.36% |
33,400
| – | – |
|
10
Affirm
AFRM
$24.6B
| $3.93M | 0.5% |
58,362
| – | – |
|
11
Air Products & Chemicals
APD
$67.7B
| $2.93M | 0.37% |
10,200
| – | – |
|
|
12
Snowflake
SNOW
$115B
| $2.9M | 0.37% |
+11,990
| New | +$2.79M |
|
13
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
$27.2B
| $2.75M | 0.35% |
5,600
| – | – |
|
14
S&P Global
SPGI
$121B
| $2.46M | 0.31% |
6,000
| – | – |
|
15
Berkshire Hathaway Class B
BRK.B
$1.09T
| $2.23M | 0.29% |
8,043
| – | – |
|
16
ExxonMobil
XOM
$657B
| $2.12M | 0.27% |
33,600
| – | – |
|
17
Pinduoduo
PDD
$127B
| $1.71M | 0.22% |
+13,480
| New | +$1.75M |
|
18
Merck
MRK
$328B
| $1.68M | 0.21% |
21,600
-1,037
| -5% | -$77.1K |
|
19
Texas Instruments
TXN
$253B
| $1.25M | 0.16% |
6,500
| – | – |
|
20
Pfizer
PFE
$150B
| $1.08M | 0.14% |
27,645
| – | – |
|
21
Walt Disney
DIS
$178B
| $1.05M | 0.13% |
6,000
| – | – |
|
22
Verizon
VZ
$195B
| $994K | 0.13% |
17,735
| – | – |
|
23
Coca-Cola
KO
$373B
| $974K | 0.12% |
18,000
| – | – |
|
24
Honeywell
HON
$74.6B
| $926K | 0.12% |
4,481
| – | – |
|
25
Wells Fargo
WFC
$269B
| $820K | 0.1% |
18,106
| – | – |
|
Similar funds
SFM
EC
EQF
NEI
FIS
CAU
IUHSA
CW
Regents of the University of California's Q2 2021 Portfolio in Review
As of Q2 2021, Regents of the University of California held 38 positions worth $784M, up 2.1% from $767M the previous quarter. Its ten largest holdings account for 96% of the portfolio.
Regents of the University of California withdrew a net $29.5M in Q2 2021, closing 4 positions and reducing 4 holdings. Its most notable exit was Allogene Therapeutics, an estimated $23.9M position sold in full.
By sector, the portfolio is most concentrated in Financials at 74% of assets, down from 78% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Regents of the University of California opened a new position in Opendoor worth $21.1M.
- Regents of the University of California's largest Q2 2021 buy was Opendoor: 1,229,182 shares worth $21.1M.
- Regents of the University of California added most to Alibaba in Q2 2021, an estimated $18.9M increase.
- Regents of the University of California's biggest Q2 2021 reduction was Blue Owl Capital, cutting an estimated $58.6M.
- Regents of the University of California fully exited Allogene Therapeutics in Q2 2021, selling an estimated $23.9M.
- Regents of the University of California's ten largest holdings make up 96% of its $784M portfolio in Q2 2021.
- Regents of the University of California opened 6 new positions and closed 4 in Q2 2021.
- Regents of the University of California's portfolio value rose 2.1% quarter-over-quarter to $784M.
Based on Regents of the University of California's 13F filing for Q2 2021, filed 27 Jul 2021.